Febrifugine
Febrifugine is a quinazolinone alkaloid that inhibits P. falciparum and has antimalarial activity. Febrifugine inhibits bladder cancer by inhibiting DNA synthesis, inducing apoptosis, and reducing steroids[1][2][3].
Product Specifications
CAS Number
24159-07-7
UNSPSC
12352005
Hazard Statement
H301, H311, H331
Target
Apoptosis; DNA/RNA Synthesis; Parasite
Type
Natural Products
Related Pathways
Anti-infection; Apoptosis; Cell Cycle/DNA Damage
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Infection
Assay Protocol
https://www.medchemexpress.com/febrifugine.html
Purity
99.98
Solubility
DMSO : 25 mg/mL (ultrasonic)
Smiles
O=C1N(CC(C[C@H]2NCCC[C@@H]2O)=O)C=NC3=C1C=CC=C3
Molecular Formula
C16H19N3O3
Molecular Weight
301.34
Precautions
H301, H311, H331
References & Citations
[1]Herman JD, et al. The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogs. Sci Transl Med. 2015 May 20;7 (288) :288ra77.|[2]Murata K, et al. Potentiation by febrifugine of host defense in mice against Plasmodium berghei NK65. Biochem Pharmacol. 1999 Nov 15;58 (10) :1593-601.|[3]Chen J, et al. Discovery of anticancer function of Febrifugine: Inhibition of cell proliferation, induction of apoptosis and suppression steroid synthesis in bladder cancer cells. Toxicol Appl Pharmacol. 2024 Mar;484:116878.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Isoform
Plasmodium
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15345196 1 Vial
Lentiviral human NUP58 shRNA (UAS) - Lentiviral human NUP58 shRNA (UAS, RFP) plasmid
Sign In for Pricing
View Details MBS1484871-01 0.02 mg (E-Coli)
Recombinant Pseudoalteromonas haloplanktis UPF0301 protein PSHAa2600 (PSHAa2600)
Sign In for Pricing
View Details